Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Income from Continuing Operations (2020 - 2025)

Biofrontera has reported Income from Continuing Operations over the past 6 years, most recently at 5640000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 5640000.0 for Q4 2025, up 504.01% from a year ago — trailing twelve months through Dec 2025 was 10536000.0 (up 40.67% YoY), and the annual figure for FY2025 was 10536000.0, up 40.67%.
  • Income from Continuing Operations for Q4 2025 was 5640000.0 at Biofrontera, up from 6649000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for BFRIW hit a ceiling of 5640000.0 in Q4 2025 and a floor of 16012000.0 in Q3 2021.
  • Median Income from Continuing Operations over the past 5 years was 3932000.0 (2021), compared with a mean of 4338900.0.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 7698.39% in 2021 and later soared 504.01% in 2025.
  • Biofrontera's Income from Continuing Operations stood at 14505000.0 in 2021, then skyrocketed by 80.8% to 2785000.0 in 2022, then surged by 226.61% to 3526000.0 in 2023, then plummeted by 139.59% to 1396000.0 in 2024, then soared by 504.01% to 5640000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 5640000.0 (Q4 2025), 6649000.0 (Q3 2025), and 5324000.0 (Q2 2025) per Business Quant data.